Clinical Trial: Enarodustat+CsA vs CsA in the Treatment of Newly-diagnosed TD-NSAA

U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07522996) titled 'Enarodustat+CsA vs CsA in the Treatment of Newly-diagnosed TD-NSAA' on March 27.

Brief Summary: This study aimed to compare the efficacy and safety of enarodustat combined with cyclosporine versus cyclosporine alone in the treatment of TD-NSAA.

Study Start Date: April, 2026

Study Type: INTERVENTIONAL

Condition: Transfusion-dependent Non-severe Aplastic Anemia

Intervention: DRUG: Enarodustat

Enarodustat 8mg qd

DRUG: Cyclosporin (CSA)

CsA 3-5mg/kg/d

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Peking Union Medical College Hospital

Information provided by (Responsible Party): Bing Han, Peking Union Medical College Hospi...